Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

NCT06336239 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT06336239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06336239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study
Lead sponsor
Beijing Anzhen Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 21, 2023
Completion date
December 30, 2024
Enrollment
3,000 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, type 2 diabetes mellitus